Loading...
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
INTRODUCTION: Enzalutamide is an oral androgen receptor (AR) signaling inhibitor that was specifically engineered to overcome castration-resistant prostate cancer (CRPC) harboring AR amplification or overexpression. Enzalutamide has demonstrated significant activity in men with metastatic CRPC. AIMS...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3622394/ https://ncbi.nlm.nih.gov/pubmed/23589709 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CE.S34747 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|